As revenue models have shifted to subscriptions, usage based pricing, projects, and multi year agreements, pipeline health stopped being a reliable proxy for revenue performance. It tells you how deals are progressing toward signature. It does not tell you how, when, or if those deals will ever turn into the revenue plan that Finance is expecting. If RevOps wants to be a strategic function, it has to move beyond pipeline health to something bigger. It has to own revenue health.
